Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model

Clear cell renal cell carcinoma (ccRCC) is the most prevalent form of renal cancer and its treatment is hindered by a resistance to targeted therapies, immunotherapies and combinations of both. We have reported that the knockdown of the antisense noncoding mitochondrial RNAs (ASncmtRNAs) with chemic...

Full description

Bibliographic Details
Main Authors: Mariela Araya, Francisca Sepúlveda, Jaime Villegas, Luis Alarcón, Luis O. Burzio, Verónica A. Burzio, Vincenzo Borgna
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/16/4/830
_version_ 1797298623118049280
author Mariela Araya
Francisca Sepúlveda
Jaime Villegas
Luis Alarcón
Luis O. Burzio
Verónica A. Burzio
Vincenzo Borgna
author_facet Mariela Araya
Francisca Sepúlveda
Jaime Villegas
Luis Alarcón
Luis O. Burzio
Verónica A. Burzio
Vincenzo Borgna
author_sort Mariela Araya
collection DOAJ
description Clear cell renal cell carcinoma (ccRCC) is the most prevalent form of renal cancer and its treatment is hindered by a resistance to targeted therapies, immunotherapies and combinations of both. We have reported that the knockdown of the antisense noncoding mitochondrial RNAs (ASncmtRNAs) with chemically modified antisense oligonucleotides induces proliferative arrest and apoptotic death in tumor cells from many human and mouse cancer types. These studies have been mostly performed in vitro and in vivo on commercially available cancer cell lines and have shown that in mouse models tumor growth is stunted by the treatment. The present work was performed on cells derived from primary and metastatic ccRCC tumors. We established primary cultures from primary and metastatic ccRCC tumors, which were subjected to knockdown of ASncmtRNAs in vitro and in vivo in an orthotopic xenograft model in NOD/SCID mice. We found that these primary ccRCC cells are affected in the same way as tumor cell lines and in the orthotopic model tumor growth was significantly reduced by the treatment. This study on patient-derived ccRCC tumor cells represents a model closer to actual patient ccRCC tumors and shows that knockdown of ASncmtRNAs poses a potential treatment option for these patients.
first_indexed 2024-03-07T22:38:42Z
format Article
id doaj.art-7848827377874c128790575bd1bc99b8
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-07T22:38:42Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-7848827377874c128790575bd1bc99b82024-02-23T15:11:22ZengMDPI AGCancers2072-66942024-02-0116483010.3390/cancers16040830Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse ModelMariela Araya0Francisca Sepúlveda1Jaime Villegas2Luis Alarcón3Luis O. Burzio4Verónica A. Burzio5Vincenzo Borgna6Centro Cientifico & Tecnologico de Excelencia Ciencia & Vida, Santiago 8580702, ChileCenter for Regenerative Medicine, Faculty of Clinical Medicine, Clínica Alemana, Universidad del Desarrollo, Santiago 7610615, ChileSchool of Veterinary Medicine, Faculty of Life Sciences, Universidad Andrés Bello, Santiago 8370251, ChileUrology Service, Hospital Barros Luco-Trudeau, Santiago 8900085, ChileDepartment of Biological Sciences, Faculty of Life Sciences, Universidad Andrés Bello, Santiago 8370251, ChileDepartment of Biological Sciences, Faculty of Life Sciences, Universidad Andrés Bello, Santiago 8370251, ChileCentro Cientifico & Tecnologico de Excelencia Ciencia & Vida, Santiago 8580702, ChileClear cell renal cell carcinoma (ccRCC) is the most prevalent form of renal cancer and its treatment is hindered by a resistance to targeted therapies, immunotherapies and combinations of both. We have reported that the knockdown of the antisense noncoding mitochondrial RNAs (ASncmtRNAs) with chemically modified antisense oligonucleotides induces proliferative arrest and apoptotic death in tumor cells from many human and mouse cancer types. These studies have been mostly performed in vitro and in vivo on commercially available cancer cell lines and have shown that in mouse models tumor growth is stunted by the treatment. The present work was performed on cells derived from primary and metastatic ccRCC tumors. We established primary cultures from primary and metastatic ccRCC tumors, which were subjected to knockdown of ASncmtRNAs in vitro and in vivo in an orthotopic xenograft model in NOD/SCID mice. We found that these primary ccRCC cells are affected in the same way as tumor cell lines and in the orthotopic model tumor growth was significantly reduced by the treatment. This study on patient-derived ccRCC tumor cells represents a model closer to actual patient ccRCC tumors and shows that knockdown of ASncmtRNAs poses a potential treatment option for these patients.https://www.mdpi.com/2072-6694/16/4/830clear cell renal cell carcinomanon-coding RNAcancer therapyorthotopic mouse renal modelpatient-derived primary cultures
spellingShingle Mariela Araya
Francisca Sepúlveda
Jaime Villegas
Luis Alarcón
Luis O. Burzio
Verónica A. Burzio
Vincenzo Borgna
Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model
Cancers
clear cell renal cell carcinoma
non-coding RNA
cancer therapy
orthotopic mouse renal model
patient-derived primary cultures
title Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model
title_full Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model
title_fullStr Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model
title_full_unstemmed Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model
title_short Knockdown of Antisense Noncoding Mitochondrial RNA Reduces Tumorigenicity of Patient-Derived Clear Cell Renal Carcinoma Cells in an Orthotopic Xenograft Mouse Model
title_sort knockdown of antisense noncoding mitochondrial rna reduces tumorigenicity of patient derived clear cell renal carcinoma cells in an orthotopic xenograft mouse model
topic clear cell renal cell carcinoma
non-coding RNA
cancer therapy
orthotopic mouse renal model
patient-derived primary cultures
url https://www.mdpi.com/2072-6694/16/4/830
work_keys_str_mv AT marielaaraya knockdownofantisensenoncodingmitochondrialrnareducestumorigenicityofpatientderivedclearcellrenalcarcinomacellsinanorthotopicxenograftmousemodel
AT franciscasepulveda knockdownofantisensenoncodingmitochondrialrnareducestumorigenicityofpatientderivedclearcellrenalcarcinomacellsinanorthotopicxenograftmousemodel
AT jaimevillegas knockdownofantisensenoncodingmitochondrialrnareducestumorigenicityofpatientderivedclearcellrenalcarcinomacellsinanorthotopicxenograftmousemodel
AT luisalarcon knockdownofantisensenoncodingmitochondrialrnareducestumorigenicityofpatientderivedclearcellrenalcarcinomacellsinanorthotopicxenograftmousemodel
AT luisoburzio knockdownofantisensenoncodingmitochondrialrnareducestumorigenicityofpatientderivedclearcellrenalcarcinomacellsinanorthotopicxenograftmousemodel
AT veronicaaburzio knockdownofantisensenoncodingmitochondrialrnareducestumorigenicityofpatientderivedclearcellrenalcarcinomacellsinanorthotopicxenograftmousemodel
AT vincenzoborgna knockdownofantisensenoncodingmitochondrialrnareducestumorigenicityofpatientderivedclearcellrenalcarcinomacellsinanorthotopicxenograftmousemodel